Swiss Re Ltd SSREY Company Overview Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2013 at 11:37 PM

Swiss Re Ltd SSREY Company Overview

Stock Message Board http://investorshangout.com/search?q=SSREY&am...mp;yt1=Go!

Swiss Re Ltd SSREY Current Price and Quotes
Last Price 76.1865
Previous Close 76.056 Open 76.44
Daily Range 76.50 - 76.10 52wk Range 86.32 - 63.32
Volume 2,414 Dividend 3.6994
Average Vol (3m) 4,506 Yield 4.8557
Swiss Re Ltd SSREY

Company Verified Profile
Company Information

Mythenquai 50/60
PO Box
Zurich 8022
Switzerland

Website: http://www.swissre.com
Phone: + 41 43 285 2121
Email: Investor_Relations@swissre.com
Find us on:

Swiss Re Ltd SSREY
The Swiss Re Group is a leading wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. Dealing direct and working through brokers, its global client base consists of insurance companies, mid-to-large-sized corporations and public sector clients. From standard products to tailor-made coverage across all lines of business, Swiss Re deploys its capital strength, expertise and innovation power to enable the risk taking upon which enterprise and progress in so...

Swiss Re Ltd SSREY
Financial Reportings and Disclosures

Reporting Status International Reporting: SIX Swiss Exchange
Audited Financials Audited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001519921
Fiscal Year End 12/31
OTC Marketplace OTCQX International Premier
Profile Data

SIC - Industry Classification 6311 - Life insurance
Incorporated In: Switzerland
Year of Inc. 1863
Employees 11350 a/o Mar 31, 2013
Company Officers/Contacts

Michel M. Lies CEO
Thomas Wellauer COO
George Quinn CFO
Guido Furer CIO
Agostino Galvagni CEO Corporate Solutions
Christian Mumenthaler Chief Marketing Officer
J. Eric Smith CEO Swiss Re Americas
Jean-Jacques Henchoz CEO Reinsurance EMEA
Moses Ojeisekhoba CEO Reinsurance Asia
David Cole Chief Risk Officer
Matthias Weber Chief Underwriting Officer
John R. Dacey Group Chief Strategy Officer, Chairman Admin Re®
Ursula Muench Executive Assistant
Simone Fessler IR
Company Directors

Walter B. Kielholz Chairman
Mathis Cabiallavetta Vice Chairman, Non-Executive Director
Renato Fassbind Vice Chairman, Non-Executive Director
Jakob Baer Non-Executive Director
Jean-Pierre Roth Non-Executive Director
C. Robert Henrikson Non-Executive Director
John R. Coomber Non-Executive Director
Rajna Gibson Brandon Non-Executive Director
Malcolm D. Knight Non-Executive Director
Raymond K.F. Ch'ien Non-Executive Director
Mary Francis Non-Executive Director
Raymund Breu Non-Executive Director
Hans Ulrich Maerki
Carlos E. Represas
Service Providers

DAD/PAL
J.P. Morgan
4 New York Plaza
14th Floor
New York, NY, 10004
United States

Auditor/Accountant
PricewaterhouseCoopers AG
Birchstrasse 160
8050 Zurich, Switzerland

Legal Counsel
Paul Weiss Rifkind Wharton & Garrison LLP
1285 Avenue of the Americas
New York, NY, 10019
United States

Investor Relations Firm
Not Available

Swiss Re Ltd SSREY
SSREY Security Details Other Company Securities

Share Structure

Market Value1 $28,242,863,599 a/o Sep 06, 2013
Shares Outstanding 370,706,931 a/o Mar 31, 2013
Float Not Available
Authorized Shares Unlimited a/o Feb 23, 2012
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (8.02585) Apr 12, 2013 Apr 16, 2013 Apr 24, 2013
Dividend (7.86246) Apr 12, 2013 Apr 16, 2013
Dividend (3.29381) Apr 17, 2012 Apr 19, 2012 Apr 27, 2012
Non US Stock Exchange Listing

SREN - SIX Swiss Exchange - Qualified
Short Selling Data

Short Interest 3,649 (166.74%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

JPMorgan Depositary Receipts

Swiss Re Ltd SSREY Recent News

Sept 4, 2013 Swiss Re: Asia Markets Continue to Attract New Capital: BestWeek Asia-Pacific, Sept. 3, 2013
Aug 28, 2013 Swiss Re: Asia Markets Continue to Attract New Capital
Aug 27, 2013 Swiss Re Survey Finds Public Willing to Pay to Mitigate Global Risks
Aug 21, 2013 A.M. BestTV Transcript: Climate Change Impact Seen Extending Far From Coasts
Aug 19, 2013 A.M. BestTV: Climate Change Impact Seen Extending Far from Coasts
Aug 15, 2013 Perrin Conferences Introduces Exclusive Insurance Company Perspective Roundtable at the 2013 Asbestos Litigation Conference
Aug 14, 2013 Rainbow International(R) Welcome Five Franchisees in Second Quarter
Aug 8, 2013 Swiss Re Posts Big Income Jump in Catastrophe-Plagued Second Quarter
Aug 1, 2013 Swiss Re Americas CEO: Climate Change Biggest Long-Term Issue Facing Insurers
Jul 24, 2013 A.M. BestTV Transcript: Cat Bond Market Soars With More Competitive Pricing

1
2
3
next >

Swiss Re Ltd SSREY Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 33,624,000 28,083,000
Cost of Revenue 21,189,000 21,245,000
Gross Profit 12,435,000 6,838,000
Operating Expenses

Research and Development - -
Sales, General and Admin. - -
Non-Recurring Items - -
Other 6,176,000 3,112,000
Operating Income 5,523,000 2,875,000
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax 6,259,000 3,726,000
Interest Expense 736,000 851,000
Earnings Before Tax 5,523,000 2,875,000
Income Tax 1,125,000 77,000
Minority Interest 141,000 172,000
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 4,398,000 2,798,000
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 4,257,000 2,626,000
Preferred Stock and Other Adjustments (56,000) -
Net Income Applicable to Common Shareholders 4,201,000 2,626,000

SSREY Swiss Re Ltd Research DD Guide

SSREY Swiss Re Ltd Stock Message Board http://investorshangout.com/search?q=SSREY&am...mp;yt0=Go!
SSREY Swiss Re Ltd Stock Quote http://www.otcmarkets.com/stock/SSREY/quote
SSREY Swiss Re Ltd Stock Chart http://www.otcmarkets.com/stock/SSREY/chart
SSREY Swiss Re Ltd Company Info http://www.otcmarkets.com/stock/SSREY/company-info
SSREY Swiss Re Ltd Recent News http://www.otcmarkets.com/stock/SSREY/news
SSREY Swiss Re Ltd Financials http://www.otcmarkets.com/stock/SSREY/financials
SSREY Swiss Re Ltd Filings and Disclosure http://www.otcmarkets.com/stock/SSREY/filings
SSREY Swiss Re Ltd Short Sales http://www.otcmarkets.com/stock/SSREY/short-sales
SSREY Swiss Re Ltd Insider Disclosure http://www.otcmarkets.com/stock/SSREY/insider-transactions
SSREY Swiss Re Ltd Research Reports http://www.otcmarkets.com/stock/SSREY/research
SSREY Swiss Re Ltd Summary http://finance.yahoo.com/q?s=SSREY
SSREY Swiss Re Ltd Historical Prices http://finance.yahoo.com/q/hp?s=SSREY+Historical+Prices
SSREY Swiss Re Ltd Interactive Chart http://finance.yahoo.com/echarts?s=SSREY
SSREY Swiss Re Ltd Basic Chart http://finance.yahoo.com/q/bc?s=SSREY+Basic+Chart
SSREY Swiss Re Ltd Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SSREY+Basic+Tech.+Analysis
SSREY Swiss Re Ltd Headlines http://finance.yahoo.com/q/h?s=SSREY+Headlines
SSREY Swiss Re Ltd Press Releases http://finance.yahoo.com/q/p?s=SSREY+Press+Releases
SSREY Swiss Re Ltd Company Profile http://finance.yahoo.com/q/pr?s=SSREY+Profile
SSREY Swiss Re Ltd Key Statistics http://finance.yahoo.com/q/ks?s=SSREY+Key+Statistics
SSREY Swiss Re Ltd Industry http://finance.yahoo.com/q/in?s=SSREY+Industry
SSREY Swiss Re Ltd Major Holders http://finance.yahoo.com/q/mh?s=SSREY+Major+Holders
SSREY Swiss Re Ltd Insider Transactions http://finance.yahoo.com/q/it?s=SSREY+Insider+Transactions
SSREY Swiss Re Ltd Insider Roster http://finance.yahoo.com/q/ir?s=SSREY+Insider+Roster
SSREY Swiss Re Ltd Income Statement http://finance.yahoo.com/q/is?s=SSREY
SSREY Swiss Re Ltd Balance Sheet http://finance.yahoo.com/q/bs?s=SSREY
SSREY Swiss Re Ltd Cash Flow http://finance.yahoo.com/q/cf?s=SSREY+Cash+Flow&annual
SSREY Swiss Re Ltd Nasdaq http://www.nasdaq.com/symbol/SSREY
SSREY Swiss Re Ltd Market Watch http://www.marketwatch.com/investing/stock/SSREY
SSREY Swiss Re Ltd Bloomberg http://www.bloomberg.com/quote/SSREY:US
SSREY Swiss Re Ltd Morningstar http://quotes.morningstar.com/stock/s?t=SSREY
SSREY Swiss Re Ltd Bussinessweek http://investing.businessweek.com/research/st...cker=SSREY
SSREY Swiss Re Ltd Barchart http://www.barchart.com/quotes/stocks/SSREY
SSREY Swiss Re Ltd OTC Short Report http://otcshortreport.com/index.php?index=SSREY
SSREY Swiss Re Ltd Investopedia http://www.investopedia.com/markets/stocks/SSREY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...